داروسازی کاسپین تامین
کاسپین | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 35,240 2.97
Close Price: 35,240
Cash Flow
AGM
Interim
2026/05/19 Fiscal Year 2026/03/2012 Month | 2026/05/16 Fiscal Year 2026/03/2012 Month / Audited | ||
|---|---|---|---|
Cash Generated from Operations | 6.881 Trillion | 6.881 Trillion | |
Income Taxes Paid | -1.836 Trillion | -1.836 Trillion | |
Net Cash Flow from Operating Activities | 5.045 Trillion | 5.045 Trillion | |
Purchases of Property, Plant and Equipment | -510.297 Billion | -510.297 Billion | |
Purchases of Intangible Assets | -4.077 Billion | -4.077 Billion | |
Dividends Received | 912 Million | 912 Million | |
Cash Received from Income on Other Investments | 14.147 Billion | 14.147 Billion | |
Net Cash Flow from Investing Activities | -499.315 Billion | -499.315 Billion | |
Net Cash Flow before Financing Activities | 4.546 Trillion | 4.546 Trillion | |
Cash Received from Borrowings | 20.03 Trillion | 20.03 Trillion | |
Repayments of Borrowings (Principal) | -15.929 Trillion | -15.929 Trillion | |
Interest Paid on Borrowings | -3.625 Trillion | -3.625 Trillion | |
Dividends Paid | -2.425 Trillion | -2.425 Trillion | |
Net Cash Flow from Financing Activities | -1.95 Trillion | -1.95 Trillion | |
Net Increase (Decrease) in Cash | 2.596 Trillion | 2.596 Trillion | |
Cash at Beginning of Period | 1.887 Trillion | 1.887 Trillion | |
Effect of Exchange Rate Changes | 120.62 Billion | 120.62 Billion | |
Cash at End of Period | 2.008 Trillion | 2.008 Trillion | |
Non-Cash Transactions | 10 Billion | 10 Billion |